Nuwellis (NUWE) Change in Receivables (2011 - 2026)
Nuwellis (NUWE) posted Change in Receivables of $66000.0 for Q1 2026, down 81.25% on a QoQ basis from $352000.0 in Q4 2025, and up 135.29% year-over-year from $28050.0 in Q1 2025.
Nuwellis (NUWE) Change in Receivables (2011 - 2026) Analysis & Trends
Nuwellis' Change in Receivables history runs 13 years deep, the most recent figure standing at $66000.0 for Q1 2026.
- Quarterly Change in Receivables rose 135.29% year-over-year to $66000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19000.0 (down 93.95% YoY) and the FY2025 annual result came in at -$234000.0, down 4.46% from the prior year.
- Change in Receivables was $66000.0 for Q1 2026 at Nuwellis, down from $352000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $526000.0 in Q4 2023 and bottomed at -$725000.0 in Q1 2024.
- A 5-year average of $47588.2 and a median of $66000.0 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables surged 1335.71% — and 2025, when it tumbled 5300.0%.
- Nuwellis' Change in Receivables stood at $306000.0 in 2022, then soared by 71.9% to $526000.0 in 2023, then declined by 17.49% to $434000.0 in 2024, then slipped by 18.89% to $352000.0 in 2025, then slumped by 81.25% to $66000.0 in 2026.
- Business Quant data shows NUWE's Change in Receivables at $66000.0 in Q1 2026, $352000.0 in Q4 2025, and -$52000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | 66,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66,000.00 |
| Mar 31, 2026 | 66,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | -52,000.00 |
| Sep 30, 2025 | -52,000.00 |
| Jun 30, 2025 | -347,000.00 |
| Jun 30, 2025 | -347,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Dec 31, 2024 | 434,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | -725,000.00 |
| Mar 31, 2024 | -725,000.00 |
| Dec 31, 2023 | 526,000.00 |
| Dec 31, 2023 | 526,000.00 |